Dive Brief: Shares in Cytokinetics sank by about one-fifth Thursday on news of a funding deal the biotechnology company struck with Royalty Pharma, in which it traded away a stake in future sales of its experimental heart drug for upfront cash. The agreement will give Cytokinetics $250 million at closing and as much as $575 […]